CopyMark Law Group
4.9/5
Drawing for AGT

USPTO serial 90680757

AGT

Reviewed by CopyMark Law Group

Reg. 6926020Status 700Registered
Filing date
Status date
Registration date
Dec 13, 2022
Examiner
FREEMAN, BREANNA SHALEISE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AGT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan N. Acquista, Esq.

Susan N. Acquista, Esq. DLA Piper LLP (US)555 Mission Street, Ste 2400San Francisco, CA 94105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, medicinal and biological preparations for modulation of patient gene expression for the treatment of diseases and conditions associated with cancer, immunological based disorders, auto-immunological based disorders, and infectious disease as may be caused by viruses, bacteria, and fungi, and inherited diseases, namely, metabolic, skeletal, muscular, dermal and neurodegenerative disorders, and for the treatment of injury, trauma, burns, or bone fractures, namely, repair of vasculature and re-innervation of tissues, and cosmetic or reconstructive tissue modificationACTIVE—
041Providing online newsletters in the fields of pharmaceuticals, medicines, treatments of diseases and medical disorders, and health; providing online non-downloadable videos in the fields of pharmaceuticals, medicines, treatments of diseases and medical disorders; online journals, namely, blogs featuring pharmaceuticals, medicines, treatments of diseases and medical disorders; educational services, namely, conducting programs in the fields of pharmaceuticals, medicines, treatments of diseases and medical disordersACTIVE—
044Medical testing services relating to the diagnosis and treatment of disease; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 13, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 13, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 9, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 8, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 5, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2022SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 4, 2022EX1GSOU EXTENSION 1 GRANTED—
Oct 4, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 26, 2022IUAFUSE AMENDMENT FILED—
Sep 26, 2022EXT1SOU EXTENSION 1 FILED—
Sep 26, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 26, 2022EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 29, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 1, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 1, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 12, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 30, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2021DOCKASSIGNED TO EXAMINER—
Aug 4, 2021MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 3, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 3, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance